Trial intelligence / Profile preview

Quetiapine for Bipolar Disorder and Alcohol Dependence

NCT00457197Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Mar 2007
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in bipolar disorder (BD), alcohol dependence, sponsored by UT Southwestern Medical Center. Started Mar 2007; status: completed.

02

Drugs

quetiapine
03

Conditions

bipolar disorder (BD)alcohol dependence

Beyond the preview

Go deeper on NCT00457197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00457197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call